Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme.
Year: 2013
Type: article
Study design: Clinical Trial
Source: PubMed
Institution: Rigshospitalet
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2118915687
